SCHEMBL9318482

SCHEMBL9318482

O=C1C[C@H]2CCCN3CCc4c(n1c1ccccc41)[C@@H]23

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 4/20 0.49
▸ LMNA P02545 3/20 0.49
▸ NR1I2 O75469 2/20 0.49
▸ CYP1A2 P05177 2/20 0.49
▸ CYP2D6 P10635 2/20 0.49
▸ TSHR P16473 2/20 0.49
▸ CYP2C9 P11712 1/20 0.49
▸ CYP2C19 P33261 1/20 0.49
▸ PDE1A P54750 8/20 0.42
▸ PDE1B Q01064 2/20 0.42
▸ PDE1C Q14123 2/20 0.42
▸ MEN1 O00255 3/20 0.37
▸ KMT2A Q03164 3/20 0.37
▸ HIF1A Q16665 2/20 0.37
▸ ALDH1A1 P00352 2/20 0.37
▸ HSD17B10 Q99714 2/20 0.37
▸ KDM4E B2RXH2 1/20 0.37
▸ CHRM2 P08172 1/20 0.37
▸ ADRA2A P08913 1/20 0.37
▸ MAPT P10636 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11982878 1.00 CYP3A4 (0.49) CYP3A4LMNANR1I2CYP1A2CYP2D6
SCHEMBL11982876 1.00 CYP3A4 (0.49) CYP3A4LMNANR1I2CYP1A2CYP2D6
SCHEMBL14543896 0.85 PDE1A (0.40) CYP3A4LMNANR1I2CYP1A2CYP2D6
SCHEMBL9664041 0.84 NR1I2 (0.37) CYP3A4LMNANR1I2CYP1A2CYP2D6
SCHEMBL9663400 0.84 MCHR1 (0.38) CYP3A4LMNANR1I2CYP1A2CYP2D6
SCHEMBL9401850 0.84 MCHR1 (0.38) CYP3A4LMNANR1I2CYP1A2CYP2D6
SCHEMBL9401823 0.84 KDM4E (0.42) CYP3A4LMNANR1I2CYP1A2CYP2D6
SCHEMBL9401622 0.84 CYP3A4 (0.37) CYP3A4LMNANR1I2CYP1A2CYP2D6
SCHEMBL9401798 0.84 LMNA (0.40) CYP3A4LMNANR1I2CYP1A2CYP2D6
SCHEMBL9401611 0.81 SLC6A4 (0.39) CYP3A4LMNANR1I2CYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5332748-A Antiischemic, antianoxic ROUSSEL-UCLAF (FR) 1994-07-26 — — US disclosed
EP-0317427-B1 Substituted derivatives of 20,21-dinoreburnamenine, process for their preparation and intermediates obtained in this way, their use as medicines, and pharmaceutical compositions containing them ROUSSEL UCLAF (FR) 1994-01-12 — — EP disclosed
US-5093337-A SUBSTITUTED DERIVATIVES OF 20,21-DINOREBURNAMENINE, THEIR USE AS MEDICAMENTS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM ROUSSEL UCLAF (FR) 1992-03-03 — — US disclosed
US-5034396-A Antidepressants ROUSSEL UCLAF (FR) 1991-07-23 — — US disclosed
WO-1989004830-A1 NEW SUBSTITUTED DERIVATIVES OF 20,21-DINOREBURNAMENINE, PROCESS FOR PREPARING THEM AND THE NEW INTERMEDIATE PRODUCTS SO OBTAINED, THEIR APPLICATION AS DRUGS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM ROUSSEL-UCLAF (FR) 1989-06-01 — — WO disclosed
EP-0317427-A1 Substituted derivatives of 20,21-dinoreburnamenine, process for their preparation and intermediates obtained in this way, their use as medicines, and pharmaceutical compositions containing them ROUSSEL-UCLAF (FR) 1989-05-24 — — EP disclosed
Send feedback